{"id":"https://openalex.org/W2116796524","doi":"https://doi.org/10.1158/0008-5472.can-13-3728","title":"Failure to Induce Apoptosis via BCL-2 Family Proteins Underlies Lack of Efficacy of Combined MEK and PI3K Inhibitors for KRAS-Mutant Lung Cancers","display_name":"Failure to Induce Apoptosis via BCL-2 Family Proteins Underlies Lack of Efficacy of Combined MEK and PI3K Inhibitors for KRAS-Mutant Lung Cancers","alternate_titles":[],"publication_year":2014,"publication_date":"2014-03-27","ids":{"openalex":"https://openalex.org/W2116796524","doi":"https://doi.org/10.1158/0008-5472.can-13-3728","mag":"2116796524","pmid":"https://pubmed.ncbi.nlm.nih.gov/24675361","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4046322"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-13-3728","doi":"https://doi.org/10.1158/0008-5472.can-13-3728","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-13-3728","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2116796524"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4046322/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087906702","display_name":"Aaron N. Hata","orcid":"https://orcid.org/0000-0002-6127-318X","observed_orcids":["https://orcid.org/0000-0002-6127-318X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron N. Hata","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","Department of Medicine, Harvard Medical School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080769435","display_name":"Alan T. Yeo","orcid":"https://orcid.org/0000-0003-0132-4587","observed_orcids":["https://orcid.org/0000-0003-0132-4587"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Yeo","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","Department of Medicine, Harvard Medical School","Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054248424","display_name":"Anthony C. Faber","orcid":"https://orcid.org/0000-0002-7246-4272","observed_orcids":["https://orcid.org/0000-0002-7246-4272"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony C. Faber","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","Department of Medicine, Harvard Medical School","Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026264693","display_name":"Eugene Lifshits","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eugene Lifshits","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","Department of Medicine, Harvard Medical School","Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100352000","display_name":"Zhao Chen","orcid":"https://orcid.org/0000-0002-5089-8731","observed_orcids":["https://orcid.org/0000-0002-5089-8731"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhao Chen","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","Department of Medicine, Harvard Medical School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044206976","display_name":"Katherine A. Cheng","orcid":"https://orcid.org/0000-0002-3375-8016","observed_orcids":["https://orcid.org/0000-0002-3375-8016"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine A. Cheng","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","Department of Medicine, Harvard Medical School","Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048286196","display_name":"Zandra E. Walton","orcid":"https://orcid.org/0000-0002-0465-0153","observed_orcids":["https://orcid.org/0000-0002-0465-0153"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zandra Walton","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","Department of Medicine, Harvard Medical School","Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022460700","display_name":"Kristopher A. Sarosiek","orcid":"https://orcid.org/0000-0002-4618-5085","observed_orcids":["https://orcid.org/0000-0002-4618-5085"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristopher A. Sarosiek","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","Department of Medicine, Harvard Medical School","Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022857112","display_name":"Anthony G. Letai","orcid":"https://orcid.org/0000-0002-1993-9013","observed_orcids":["https://orcid.org/0000-0002-1993-9013"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony Letai","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","Department of Medicine, Harvard Medical School","Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064382279","display_name":"Rebecca Suk Heist","orcid":"https://orcid.org/0000-0002-7397-2009","observed_orcids":["https://orcid.org/0000-0002-7397-2009"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca S. Heist","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","Department of Medicine, Harvard Medical School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072389805","display_name":"Mari A. Mino-Kenudson","orcid":"https://orcid.org/0000-0002-9092-2265","observed_orcids":["https://orcid.org/0000-0002-9092-2265"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mari Mino-Kenudson","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","Department of Medicine, Harvard Medical School","Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019034689","display_name":"Kwok\u2010Kin Wong","orcid":"https://orcid.org/0000-0001-6323-235X","observed_orcids":["https://orcid.org/0000-0001-6323-235X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kwok-Kin Wong","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","Department of Medicine, Harvard Medical School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040093136","display_name":"Jeffrey A. Engelman","orcid":"https://orcid.org/0009-0004-0775-4523","observed_orcids":["https://orcid.org/0009-0004-0775-4523"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jeffrey A. Engelman","raw_affiliation_strings":["Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","Department of Medicine, Harvard Medical School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Massachusetts General Hospital Cancer Center, Charlestown; 2Department of Medicine, Harvard Medical School; 3Department of Medical Oncology, Dana-Farber Cancer Institute; and 4Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School","institution_ids":["https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5040093136"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915","https://openalex.org/I4210117453"],"apc_list":null,"apc_paid":null,"fwci":3.6444,"has_fulltext":false,"cited_by_count":85,"citation_normalized_percentile":{"value":0.94808197,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"74","issue":"11","first_page":"3146","last_page":"3156"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.49219998717308044,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.49219998717308044,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.34060001373291016,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.020099999383091927,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kras-mutant-non-small-cell-lung-cancer","display_name":"KRAS-mutant non-small cell lung cancer","score":0.9120000004768372},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.9279999732971191},{"id":"https://openalex.org/keywords/pi3k-inhibitors","display_name":"PI3K inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6869999766349792},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8460000157356262},{"id":"https://openalex.org/keywords/bcl-2-family-proteins","display_name":"Bcl-2 family proteins","score":0.9929999709129333},{"id":"https://openalex.org/keywords/building-information-modeling","display_name":"building information modeling","score":0.9940000176429749},{"id":"https://openalex.org/keywords/puma","display_name":"PUMA","score":1.0},{"id":"https://openalex.org/keywords/bcl-xl","display_name":"Bcl-xL","score":1.0},{"id":"https://openalex.org/keywords/adaptive-drug-resistance","display_name":"adaptive drug resistance","score":0.640999972820282},{"id":"https://openalex.org/keywords/intrinsic-drug-resistance","display_name":"intrinsic drug resistance","score":0.8569999933242798},{"id":"https://openalex.org/keywords/growth-arrest","display_name":"growth arrest","score":0.48899999260902405}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.9198021292686462},{"id":"https://openalex.org/C2777417711","wikidata":"https://www.wikidata.org/wiki/Q270748","display_name":"Puma","level":3,"score":0.8573222756385803},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.6635563373565674},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6266524791717529},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6257972717285156},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.6093598008155823},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.49770858883857727},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4867229759693146},{"id":"https://openalex.org/C190232843","wikidata":"https://www.wikidata.org/wiki/Q1950808","display_name":"Small hairpin RNA","level":4,"score":0.4786466360092163},{"id":"https://openalex.org/C2778502085","wikidata":"https://www.wikidata.org/wiki/Q7662767","display_name":"Synthetic lethality","level":4,"score":0.451865017414093},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4473881423473358},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43511635065078735},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.42517444491386414},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33094722032546997},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.20435026288032532},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15177753567695618},{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.12509149312973022},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08197614550590515},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000081082","descriptor_name":"Phosphoinositide-3 Kinase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008928","descriptor_name":"Mitochondria","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008928","descriptor_name":"Mitochondria","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008928","descriptor_name":"Mitochondria","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018631","descriptor_name":"ras Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D018631","descriptor_name":"ras Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020935","descriptor_name":"MAP Kinase Signaling System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D020935","descriptor_name":"MAP Kinase Signaling System","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051017","descriptor_name":"Apoptosis Regulatory Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051017","descriptor_name":"Apoptosis Regulatory Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051020","descriptor_name":"bcl-X Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051020","descriptor_name":"bcl-X Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/0008-5472.can-13-3728","doi":"https://doi.org/10.1158/0008-5472.can-13-3728","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-13-3728","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:24675361","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24675361","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4046322","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4046322/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Cancer Res","raw_type":"Text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.723.3821","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.723.3821","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://research4.dfci.harvard.edu/letai/Publications/2014_03_Cancer%20Research_Letai.pdf","raw_type":"text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4046322","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4046322/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Cancer Res","raw_type":"Text"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1172700517","display_name":"MUC1-C Oncoprotein Evades Immune Destruction in Non-small Cell Lung Cancer","funder_award_id":"R01CA166480","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G1374307341","display_name":"The Co-Clinical Trial Project","funder_award_id":"U01CA141457","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2267973827","display_name":"The Co-Clinical Project: Informing clinical trials using preclinical mouse models","funder_award_id":"RC2CA147940","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2850547368","display_name":"In vivo analysis of EGFR mutant driven lung cancers responses to radiation therap","funder_award_id":"R01CA122794","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G369962788","display_name":"Therapeutic strategies for specific subsets of KRAS mutant lung cancers","funder_award_id":"R01CA140594","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4752445381","display_name":"Dana-Farber/Harvard Cancer Center SPORE in Lung Cancer","funder_award_id":"P50CA090578","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8069840808","display_name":"Mouse Models and Translational Studies of Endometrial Cancer","funder_award_id":"R01CA137181","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000903436","display_name":"Non-genomic resistance mechanisms in EGFR-mutant lung cancer","funder_award_id":"R01CA137008","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332898","display_name":"Stand Up To Cancer","ror":"https://ror.org/01dmpb598"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1498900438","https://openalex.org/W1967913221","https://openalex.org/W1980497534","https://openalex.org/W1982967858","https://openalex.org/W1988878042","https://openalex.org/W1990408342","https://openalex.org/W1998971866","https://openalex.org/W1999025555","https://openalex.org/W2001999652","https://openalex.org/W2004691500","https://openalex.org/W2009333774","https://openalex.org/W2083797848","https://openalex.org/W2084875329","https://openalex.org/W2090657374","https://openalex.org/W2091134276","https://openalex.org/W2093917816","https://openalex.org/W2094207365","https://openalex.org/W2097007474","https://openalex.org/W2100626226","https://openalex.org/W2102088611","https://openalex.org/W2104830962","https://openalex.org/W2105889692","https://openalex.org/W2113327188","https://openalex.org/W2114408324","https://openalex.org/W2116104243","https://openalex.org/W2116177527","https://openalex.org/W2117551758","https://openalex.org/W2117986690","https://openalex.org/W2123879591","https://openalex.org/W2125789330","https://openalex.org/W2129360604","https://openalex.org/W2131876608","https://openalex.org/W2132157071","https://openalex.org/W2134964552","https://openalex.org/W2152636515","https://openalex.org/W2168735820","https://openalex.org/W2172242534","https://openalex.org/W2336866290","https://openalex.org/W2602871482","https://openalex.org/W2738422874","https://openalex.org/W2956607982"],"related_works":["https://openalex.org/W1998861590","https://openalex.org/W2892395616","https://openalex.org/W2740337971","https://openalex.org/W2956097485","https://openalex.org/W1987138368","https://openalex.org/W2320994390","https://openalex.org/W2039442846","https://openalex.org/W4403419614","https://openalex.org/W4387811495"],"abstract_inverted_index":{"Although":[0],"several":[1],"groups":[2],"have":[3,37,177],"demonstrated":[4],"that":[5,74,192],"concomitant":[6],"use":[7],"of":[8,24,54,60,100,108,118,131,141,174,185,202],"MEK":[9],"and":[10,126,143,165,187,211],"phosphoinositide":[11],"3-kinase":[12],"(PI3K)":[13],"inhibitors":[14],"(MEKi/PI3Ki)":[15],"can":[16],"induce":[17,196],"dramatic":[18],"tumor":[19,94],"regressions":[20],"in":[21,57,86,96,148,163,166],"mouse":[22],"models":[23],"KRAS-mutant":[25,61,77,205],"non-small":[26],"cell":[27,79,149],"lung":[28],"cancer":[29],"(NSCLC),":[30],"ongoing":[31],"clinical":[32],"trials":[33],"investigating":[34],"this":[35,70,215],"strategy":[36],"been":[38,66],"underwhelming":[39],"to":[40,63,82,88,146,160,183,195,209,214],"date.":[41],"While":[42],"efficacy":[43],"may":[44,198],"be":[45],"hampered":[46],"by":[47,136,156,207],"a":[48,112,178],"narrow":[49],"therapeutic":[50],"index,":[51],"the":[52,58,132,172,193,200],"contribution":[53],"biologic":[55],"heterogeneity":[56,99],"response":[59,87,102,134,181],"NSCLCs":[62,206],"MEKi/PI3Ki":[64,161,203],"has":[65],"largely":[67],"unexplored.":[68],"In":[69,154],"study,":[71],"we":[72,122,168],"find":[73,169],"most":[75],"human":[76],"NSCLC":[78],"lines":[80,150],"fail":[81],"undergo":[83],"marked":[84],"apoptosis":[85,197],"MEKi/PI3Ki,":[89,137],"which":[90],"is":[91],"key":[92,129],"for":[93,204],"responsiveness":[95],"vivo.":[97],"This":[98],"apoptotic":[101,133,180],"occurs":[103],"despite":[104],"relatively":[105],"uniform":[106],"induction":[107],"growth":[109],"arrest.":[110],"Using":[111],"targeted":[113],"short":[114],"hairpin":[115],"RNA":[116],"screen":[117],"BCL-2":[119],"family":[120],"members,":[121],"identify":[123],"BIM,":[124],"PUMA,":[125],"BCL-XL":[127,147],"as":[128],"regulators":[130],"induced":[135],"with":[138,151],"decreased":[139],"expression":[140],"BIM":[142,186],"PUMA":[144],"relative":[145],"intrinsic":[152,210],"resistance.":[153],"addition,":[155],"modeling":[157],"adaptive":[158,212],"resistance":[159,213],"both":[162],"vitro":[164],"vivo,":[167],"that,":[170],"upon":[171],"development":[173],"resistance,":[175],"tumors":[176],"diminished":[179],"due":[182],"downregulation":[184],"PUMA.":[188],"These":[189],"results":[190],"suggest":[191],"inability":[194],"limit":[199],"effectiveness":[201],"contributing":[208],"therapy.":[216]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2116796524","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":7}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2016-06-24T00:00:00"}
